FIELD: organic chemistry, medicine, oncology, biochemistry, pharmacy.
SUBSTANCE: invention relates to novel tricyclic compounds, their pharmaceutically acceptable salts and solvates useful for inhibition of activity of farnesyl-protein-transferase. Invention describes compound of the formula (1.0): or its pharmaceutically acceptable salt or solvate wherein one among a, b, c and d means nitrogen atom (N) or -N+O-, and other a, b, c and d mean carbon atom and wherein each carbon atom comprises radical R1 or R2 bound to indicated carbon atom; or all a, b, c and d mean carbon atom wherein each carbon atom comprises radical R1 or R2 bound to indicated carbon atom; broken line (- - -) means optional binds; X means N or -CH when optional bond is absent, and it means carbon atom (C) when optional bond presents; when optional bond between carbon atom 5 and carbon atom 6 presents then only a single substitute A presents bound with carbon atom 5, and only a single substitute B presents bound with carbon atom 6, and A and B fifer from hydrogen atom (H); if optional bind between carbon atom 5 and carbon atom 6 is absent then two substitutes A present bound with carbon atom 5, and two substitutes B bound with carbon atom 6 wherein at least one of two substitutes A or one among two substitutes B mean H and wherein at least one of two substitutes A or one of two substitutes B has value distinct from H, and other radical are described in the invention claim. Also, invention disclosed a pharmaceutical composition comprising such compounds, a method for inhibition of anomalous growth of cells and methods for treatment of proliferative diseases as cancer.
EFFECT: valuable medicinal properties of compounds and pharmaceutical composition, improved method of treatment.
52 cl, 2 tbl, 505 ex
Title | Year | Author | Number |
---|---|---|---|
PYRAZOLOPYRIMIDINE DERIVATIVES AS CYCLIN-DEPENDENT KINASE INHIBITORS | 2005 |
|
RU2414472C9 |
POLYCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION POSSESSING PROPERTY OF H RECEPTOR ANTAGONIST AND METHOD FOR TREATMENT BY ITS USING | 2001 |
|
RU2301231C2 |
DERIVATIVES OF PIPERAZINE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF AND USING AS CCR5 ANTAGONISTS | 2000 |
|
RU2299206C9 |
PYRROLIDINE AND PIPERIDINE DERIVATIVES | 2002 |
|
RU2326120C9 |
PEPTIDILE HETEROCYCLES USED TO TREAT THROMBIN- ASSOCIATED DISEASES | 1996 |
|
RU2181125C2 |
METHOD FOR PREPARING ENANTIOMERICALLY ENRICHED TETRAHYDROBENZOTHIEPINE OXIDES | 1998 |
|
RU2236406C2 |
DERIVATIVES OF PIPERIDINE, PHARMACEUTICAL COMPOSITION ON THEIR BASIS AND THEIR APPLICATION | 2005 |
|
RU2408591C9 |
METHODS AND INTERMEDIATE COMPOUNDS | 2010 |
|
RU2531588C2 |
TRICYCLIC ANTAGONISTS OF THROMBIN RECEPTORS | 2003 |
|
RU2329264C9 |
SYMMETRIC AND ASYMMETRIC DERIVATIVES OF DIPHENYLUREA (VARIANTS), PHARMACEUTICAL COMPOSITION, METHOD FOR INHIBITION OF RAF KINASE- MEDIATED TUMOR CELLS PROLIFERATION | 1998 |
|
RU2247109C9 |
Authors
Dates
2007-02-20—Published
2001-08-28—Filed